Hematology analyser are automated systems used in the medical laboratory to count leucocytes, red cells and platelets in blood. Moreover, it also helps to determine haemoglobin and haematocrit levels. It analyses the properties of blood and other fluids which further help in helps in diagnosis of various diseases. With increasing technological advancement and research and development in the haematology analysers the new analyzers are capable of processing hundreds of samples an hour. The hematology analyzerers market shows a significant growth due to technological developments, rinsing incidences of blood disorders globally, rise in public awareness and healthcare spending in developed and developing countries.
However, rising adoption and demand for advanced hematology Instruments in developing countries and excessive cost associated with the hematology analyzers products are the factors hindering the growth of the market. The report analysis the hematology analyzers market based on type into 5-part and 6-part fully automated hematology analyzers, 3-part fully automated hematology analyzers, semi-automated hematology analyzers and point-of-care testing hematology analyzers . In 2017, the point of care testing hematology analyzers dominated the hematology analyzer market and is expected to maintain its dominance during the forecast period. increasing adoption of point of care testing hematology analyzers coupled with new product launches and rising preference towards automation is fuelling the growth of the market.
By end user, the hematology analyzers market is segmented into hospital laboratories, clinical testing labs, research and academic institutes, commercial organizations and others including government reference laboratories. The clinical testing labs segment is expected to grow at a faster pace during the forecast period owing to factor like increasing rate chronic lead poisoning and sickle cell disease, rising incidences of blood-related disorders such as hereditary spherocytosis and cytochemistries among the people and identification of chronic granulomatous disease globally.
By geography hematology analyzers market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads the global hematolgy analyzers market and accounted for the largest market share. The growth of the North America hematology analyzers market is driven by factors such as rising prevalence of patients suffering from blood disorders, increasing rate target diseases and high disposable income of the people in the region.
Some of the key participants in the hematology analyzers market are Abbott Laboratories, Beckman Coulter, Inc, HORIBA Ltd, Bio-Rad Laboratories, Mindray Medical International Ltd, Boule Diagnostics AB, Nihon Kohden, Roche, Sysmex, Biosystems (A Part of Ginper Group), Drew Scientific, etc. Beckman Coulter, Inc. is the leader in the hematology analyser market and launched a new hematology analyzer software that support and enhab=nces the performance of the new and existing DxH 500 hematology analyzers. Mergers, agreements, strategic partnerships, new product development and technological advancement are the key growth strategies adopted by the major players to gain maximum market share globally.